These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6855001)

  • 1. [Evaluation of prothrombin time and thrombotest and hepaplastin test for the control of oral anticoagulant therapy].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Feb; 31(2):210-4. PubMed ID: 6855001
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monitoring for oral anticoagulant therapy].
    Nakagawa K; Nakahara Y; Tsuji H
    Rinsho Ketsueki; 1995 Apr; 36(4):308-13. PubMed ID: 7783335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Jan; 31(1):105-9. PubMed ID: 6865023
    [No Abstract]   [Full Text] [Related]  

  • 4. [Control of heparin and oral anticoagulants, with micromethods: thrombin time, quick determination with addition of protamine].
    Seiler K; Müller G; Duckert F
    Schweiz Med Wochenschr; 1970 Sep; 100(36):1522-8. PubMed ID: 5524716
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of anticoagulant therapy. A comparative study of heparin tolerance test and prothrombin time estimation.
    Saifi MF; Shalaby ES; el-Masri B; Gadalla IG; Afifi N
    J Egypt Med Assoc; 1974; 57(1-2):36-40. PubMed ID: 4452750
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peroral anticoagulant therapy--are the TT-values reliable?].
    Eilertsen H; Asprang AF; Ulveland K; Nerdrum HJ
    Tidsskr Nor Laegeforen; 1998 Apr; 118(11):1690-2. PubMed ID: 9621756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of laboratory monitoring in oral anticoagulant therapy].
    D'Angelo G; Calvano D; Giardini C
    Minerva Med; 1993 Jun; 84(6):313-22. PubMed ID: 8336839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of plasma prothrombin level by Ca2+-dependent prothrombin activator (CA-1) during warfarin anticoagulation.
    Iwahashi H; Kimura M; Nakajima K; Yamada D; Morita T
    J Heart Valve Dis; 2001 May; 10(3):388-92. PubMed ID: 11380105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of warfarin on thrombosis of the jugular veins of rabbits induced by prolonged stasis.
    Foschi D; Scagnol I; Radaelli E; Pace M; Trabucchi E
    Drugs Exp Clin Res; 1993; 19(4):183-8. PubMed ID: 8131714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting patients' warfarin requirements.
    Routledge PA; Davies DM; Bell SM; Cavanagh JS; Rawlins MD
    Lancet; 1977 Oct; 2(8043):854-5. PubMed ID: 72199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombotest, hepaplastin test].
    Mitsuhashi H; Kinouchi T
    Nihon Rinsho; 1999 Sep; 57 Suppl():555-8. PubMed ID: 10543176
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombotest (TBT), hepaplastin test (HPT)].
    Ueda M
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():14-7. PubMed ID: 8753169
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methods for the control of anticoagulant therapy].
    Lechner K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):129-39. PubMed ID: 4098767
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation.
    Jennings I; Luddington RJ; Baglin T
    J Clin Pathol; 1991 Nov; 44(11):950-3. PubMed ID: 1752987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 19. The management of patients on chronic Coumadin therapy undergoing subsequent surgical procedures.
    Madura JA; Rookstool M; Wease G
    Am Surg; 1994 Jul; 60(7):542-6; discussion 546-7. PubMed ID: 8010570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation.
    Ascani A; Iorio A; Agnelli G
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.